Molecular analysis by sequencing crucial cancer genes, exomes, RNA, and targeted proteomics identified uniform KRAS, TP53, and PIK3CA driver gene mutations in all parallel cultures, but also provided evidence for substantial ITH. The gene discussed is TP53; the disease is cancer.